story of the week
Topical 5% 5-Fluorouracil Versus Procedural Modalities for Squamous Cell Carcinoma In Situ and Superficial Basal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis
J Am Acad Dermatol 2021 Aug 31;[EPub Ahead of Print], H Neale, M Michelon, S Jacob, M Pinkston, R Ukaegbu, W Zamor, E Morrison, A Deng, NA LevinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.